US SB2039 | 2023-2024 | 118th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on June 15 2023 - 25% progression
Action: 2023-06-15 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Cancer Drug Parity Act of 2023

Sponsors


History

DateChamberAction
2023-06-15SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.

Same As/Similar To

HB6301 (Same As) 2023-11-08 - Referred to the House Committee on Education and the Workforce.

Subjects


US Congress State Sources


Bill Comments

feedback